Veterinary Medicines

Catosal 100 mg/ml + 0.05 mg/ml solution for injection for cattle, horses and dogs

Authorised
  • Butafosfan
  • Cyanocobalamin
Download as PDF

Product identification

Medicine name:
Catosal 100 mg/ml + 0,05 mg/ml raztopina za injiciranje za govedo, konje in pse
Catosal 100 mg/ml + 0.05 mg/ml solution for injection for cattle, horses and dogs
Active substance:
  • Butafosfan
  • Cyanocobalamin
Target species:
  • Cattle
  • Dog
  • Horse
Route of administration:
  • Intravenous use
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Butafosfan
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Cyanocobalamin
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Dog
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
  • Intramuscular use
    • Dog
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • (ID2) 250 millilitre(s): Box (Cardboard) with 1 Vial (Glass type I) with 250 millilitre(s), closed with Stopper and Cap and Stopper and Cap (chlorobutyl rubber`, Aluminium, chlorobutyl rubber`, Aluminium)
  • (ID1) 100 millilitre(s): Box (Cardboard) with 1 Vial (Glass type II) with 100 millilitre(s), closed with Stopper and Cap and Cap and Stopper (chlorobutyl rubber`, Aluminium, Aluminium, chlorobutyl rubber`)
  • (ID3) 50 millilitre(s): Box (Cardboard) with 1 Vial (Glass type II) with 50 millilitre(s), closed with Stopper and Cap (chlorobutyl rubber`, Aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • MR/V/0059/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/01/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/01/2025
Download

Combined File of all Documents

English (PDF)
Published on: 5/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."